Showing results (51-60 of 2,686) with videos related to

Sort By:
Pageof 269
The Lancet. Infectious Diseases|September 6, 2014
Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spreadBrian McCloskey, Osman Dar, Alimuddin Zumla, et al.
The Lancet. Infectious Diseases|September 5, 2014
Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept studyDamien Portevin, Felicien Moukambi, Petra Clowes, et al.
The Lancet. Infectious Diseases|April 8, 2016
Association of gestational age and growth measures at birth with infection-related admissions to hospital throughout childhood: a population-based, data-linkage study from Western AustraliaJessica E Miller, Geoffrey C Hammond, Tobias Strunk, et al.
The Lancet. Infectious Diseases|April 11, 2016
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studiesEdward A Belongia, Melissa D Simpson, Jennifer P King, et al.
The Lancet. Infectious Diseases|March 13, 2016
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysisFrancisco M Marty, Luis Ostrosky-Zeichner, Oliver A Cornely, et al.
The Lancet. Infectious Diseases|March 14, 2016
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging studyJoshua Rhein, Bozena M Morawski, Kathy Huppler Hullsiek, et al.
The Lancet. Infectious Diseases|June 26, 2016
Global burden of drug-resistant tuberculosis in children: a mathematical modelling studyPeter J Dodd, Charalambos Sismanidis, James A Seddon
The Lancet. Infectious Diseases|July 4, 2016
Efficacy of topical mosquito repellent (picaridin) plus long-lasting insecticidal nets versus long-lasting insecticidal nets alone for control of malaria: a cluster randomised controlled trialVincent Sluydts, Lies Durnez, Somony Heng, et al.
The Lancet. Infectious Diseases|July 5, 2016
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE studyCosette M Wheeler, S Rachel Skinner, M Rowena Del Rosario-Raymundo, et al.
The Lancet. Infectious Diseases|February 28, 2012
Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infectionsNicolas Dauby, Tessa Goetghebuer, Tobias R Kollmann, et al.
Pageof 269